58 related articles for article (PubMed ID: 11564685)
1. The regulation of MAPKs in Y1 mouse adrenocortical tumor cells.
Le T; Schimmer BP
Endocrinology; 2001 Oct; 142(10):4282-7. PubMed ID: 11564685
[TBL] [Abstract][Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
3. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis.
Fassnacht M; Hahner S; Hansen IA; Kreutzberger T; Zink M; Adermann K; Jakob F; Troppmair J; Allolio B
J Clin Endocrinol Metab; 2003 May; 88(5):2171-9. PubMed ID: 12727972
[TBL] [Abstract][Full Text] [Related]
4. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
Ahmed KM; Dong S; Fan M; Li JJ
Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
[TBL] [Abstract][Full Text] [Related]
6. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
7. Differences between the growth regulatory pathways in primary rat adrenal cells and mouse tumor cell line.
Mattos GE; Lotfi CF
Mol Cell Endocrinol; 2005 Dec; 245(1-2):31-42. PubMed ID: 16289304
[TBL] [Abstract][Full Text] [Related]
8. Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells.
Lotfi CF; Todorovic Z; Armelin HA; Schimmer BP
J Biol Chem; 1997 Nov; 272(47):29886-91. PubMed ID: 9368063
[TBL] [Abstract][Full Text] [Related]
9. MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors.
Pereira SS; Monteiro MP; Costa MM; Ferreira J; Alves MG; Oliveira PF; Jarak I; Pignatelli D
J Cell Biochem; 2019 Jan; 120(1):894-906. PubMed ID: 30256438
[TBL] [Abstract][Full Text] [Related]
10. Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells.
Lin X; Takemori H; Katoh Y; Doi J; Horike N; Makino A; Nonaka Y; Okamoto M
Mol Endocrinol; 2001 Aug; 15(8):1264-76. PubMed ID: 11463852
[TBL] [Abstract][Full Text] [Related]
11. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
12. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
Panet R; Eliash M; Atlan H
J Cell Physiol; 2006 Mar; 206(3):578-85. PubMed ID: 16222701
[TBL] [Abstract][Full Text] [Related]
13. When expressed in yeast, mammalian mitogen-activated protein kinases lose proper regulation and become spontaneously phosphorylated.
Levin-Salomon V; Maayan I; Avrahami-Moyal L; Marbach I; Livnah O; Engelberg D
Biochem J; 2009 Jan; 417(1):331-40. PubMed ID: 18778243
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes.
Clerk A; Harrison JG; Long CS; Sugden PH
J Mol Cell Cardiol; 1999 Dec; 31(12):2087-99. PubMed ID: 10640438
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras.
Page K; Li J; Hershenson MB
Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1294-302. PubMed ID: 10340949
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
Taylor CC
Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
[TBL] [Abstract][Full Text] [Related]
17. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
18. Role of ERK/MAP kinase in mitogenic interaction between ACTH and FGF2 in mouse Y1 adrenocortical tumor cells.
Lotfi CF; Costa ET; Schwindt TT; Armelin HA
Endocr Res; 2000 Nov; 26(4):873-7. PubMed ID: 11196465
[TBL] [Abstract][Full Text] [Related]
19. Proliferative signaling initiated in ACTH receptors.
Lotfi CF; Lepique AP; Forti FL; Schwindt TT; Eichler CB; Santos MO; Rebustini IT; Hajj GN; Juliano L; Armelin HA
Braz J Med Biol Res; 2000 Oct; 33(10):1133-40. PubMed ID: 11004713
[TBL] [Abstract][Full Text] [Related]
20. Optimizing photoswitchable MEK.
Patel AL; Yeung E; McGuire SE; Wu AY; Toettcher JE; Burdine RD; Shvartsman SY
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25756-25763. PubMed ID: 31796593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
